Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05440084 · ClinicalTrials.gov registry record
Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity
A clinical trial, sponsored by Minneapolis Heart Institute Foundation.
- Terminated
- Registry status
- 1
- Enrollment target
NCT05440084 is a clinical trial that was terminated before completion, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 1 participants.
The verdict
NCT05440084 was terminated before completion, sponsored by Minneapolis Heart Institute Foundation.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
Heart disease is a leading cause of death in the US. . Heart blood vessel chronic total occlusions are 100% blockages of the heart vessels. These patients often suffer from chest pain, shortness of breath, and depression. Heart doctors thread special cables from the groin and wrist to the heart and open up these 100% blocked vessels. . This treatment improves symptoms and quality of life. Exercise is very beneficial for health. Previous studies suggest that even a 1000 steps/day increase in daily steps can improve health. But, patients with occluded heart vessels are often inactive because they have chest pain, feeling tired, or are short of breath. It is unknown whether opening these 100% blocked heart vessels will help patients have a more active lifestyle, which is good for health. The goal is to measure the impact of opening these occluded heart vessels on daily exercise in this project. Specifically, the investigators will give a smart watch to patients referred for this treatment. The smart watch will track the patients' daily steps before and after the procedure.
Interventions
- PROCEDURE Chronic total occlusion percutaneous coronary intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2024-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05440084
The ClinicalTrials.gov registry entry for NCT05440084 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chronic total occlusion percutaneous coronary intervention is the first listed.
NCT05440084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05440084 about?
NCT05440084 is a clinical study titled "Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity". Heart disease is a leading cause of death in the US. . Heart blood vessel chronic total occlusions are 100% blockages of the heart vessels. These patients often suffer from chest pain, shortness of breath, and depression. Heart doctors thread special cables from the groin and wrist to the heart and ...
What is the current status of trial NCT05440084?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2022-09-01. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT05440084?
The interventions under investigation include: Chronic total occlusion percutaneous coronary intervention (PROCEDURE).
Who is sponsoring clinical trial NCT05440084?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.